Evidence map›Paper›PMID 29880251›Full record

ArticleBioorganic & medicinal chemistry2018

Expedient synthesis and biological evaluation of alkenyl acyclic nucleoside phosphonate prodrugs.

Elisa Pileggi, Michaela Serpi, Graciela Andrei, Dominique Schols, Robert Snoeck, Fabrizio Pertusati

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elisa PileggiSchool of Pharmacy and Pharmaceutical Sciences, Redwood building, King Edwards VII Avenue, CF10 3NB Cardiff, Wales, United Kingdom.
Michaela SerpiSchool of Pharmacy and Pharmaceutical Sciences, Redwood building, King Edwards VII Avenue, CF10 3NB Cardiff, Wales, United Kingdom.
Graciela AndreiRega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium.
Dominique ScholsRega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium.
Robert SnoeckRega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium.
Fabrizio PertusatiSchool of Pharmacy and Pharmaceutical Sciences, Redwood building, King Edwards VII Avenue, CF10 3NB Cardiff, Wales, United Kingdom. Electronic address: pertusatif1@cf.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The importance of phosphonoamidate prodrugs (ProTides) of acyclic nucleoside phosphonate (ANPs) is highlighted by the approval of Tenofovir Alafenamide Fumarate for the treatment of HIV and HBV infections. In the present paper we are reporting an expedient, one-pot, two-steps synthesis of allyl phosphonoamidates and diamidates that offers a time saving strategy when compared to literature methods. The use of these substrates in the cross metathesis reactions with alkenyl functionalised thymine and uracil nucleobases is reported. ANPs prodrugs synthesized via this methodology were evaluated for their antiviral activities against DNA and RNA viruses. It is anticipated that the use of 5,6,7,8-tetrahydro-1-napthyl as aryloxy moiety is capable to confer antiviral activity among a series of otherwise inactive uracil ProTides.

Indexed as

Antiviral AgentsCell LineDNA VirusesDrug StabilityHumansNucleosidesOrganophosphonatesProdrugsRNA VirusesStructure-Activity RelationshipAntiviral AgentsNucleosidesOrganophosphonatesProdrugs

Identifiers

PMID29880251
PMCPMC7126595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.